BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
BusinessHalozyme Therapeutics completes $1.5 billion convertible notes offeringBusinessXCF Global reports $10M August renewable diesel revenueBusinessAbeona Therapeutics stock reiterated at Buy by H.C. WainwrightBusinessCoya Therapeutics stock maintained at Buy by H.C. WainwrightBusinessH.C. Wainwright reiterates Ultragenyx stock rating on FDA approval
Business/Source-attributed reporting
Business DESK

Halozyme Therapeutics completes $1.5 billion convertible notes offering

Published Sep 22, 2026 · 5:00 PMOriginal source: All News8 reads
Halozyme Therapeutics completes $1.5 billion convertible notes offering
ORIGINAL SOURCE

All News

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗
RELATED COVERAGE

More from this desk.